Ergoteles’s Savara SVRA Stock Holding History

Ergoteles’s Portfolio SVRA Stock Details SVRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-76,968	Closed	-$106K	–	1576
2021 Q3	$106K	Sell	76,968 -132,132	-63%	-$178K	﹤0.01%	1096
2021 Q2	$355K	Buy	+209,100	New	+$376K	0.01%	987

Other funds holding SVRA

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ergoteles's SVRA Position: Q4 2021 in Review

Ergoteles sold out of Savara (SVRA) in Q4 2021, closing a stake of 76,968 shares — an estimated $106K sold.

Ergoteles first reported a position in SVRA in Q2 2021 and held it in 2 quarters. The position peaked at $355K in Q2 2021. 54 funds tracked by Wall St. Rank hold SVRA as of Q4 2021.

Ergoteles reported no remaining Savara position as of Q4 2021 after selling out during the quarter.
Ergoteles sold 76,968 Savara shares in Q4 2021, an estimated $106K.
Ergoteles first reported a position in Savara in Q2 2021 and held it in 2 quarters.
Ergoteles's Savara position peaked at $355K in Q2 2021.
54 funds tracked by Wall St. Rank held Savara as of Q4 2021.

Based on Ergoteles's 13F filing for Q4 2021, filed 14 Feb 2022.